124 related articles for article (PubMed ID: 8792920)
21. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
[TBL] [Abstract][Full Text] [Related]
22. Seasonal differences in airway hyperresponsiveness in asthmatic patients: relationship with allergen exposure and sensitization to house dust mites.
van der Heide S; De Monchy JG; De Vries K; Dubois AE; Kauffman HF
Clin Exp Allergy; 1997 Jun; 27(6):627-33. PubMed ID: 9208182
[TBL] [Abstract][Full Text] [Related]
23. Inhaled beclomethasone improves the course of asthma and COPD.
Dompeling E; van Schayck CP; Molema J; Folgering H; van Grunsven PM; van Weel C
Eur Respir J; 1992 Sep; 5(8):945-52. PubMed ID: 1426202
[TBL] [Abstract][Full Text] [Related]
24. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
25. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma.
Meltzer EO; Orgel HA; Ellis EF; Eigen HN; Hemstreet MP
J Allergy Clin Immunol; 1992 Jul; 90(1):2-11. PubMed ID: 1629506
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of inhaled steroids (beclomethasone dipropionate) for treatment of mild to moderately severe asthma in the emergency department: a randomized clinical trial.
Afilalo M; Guttman A; Colacone A; Dankoff J; Tselios C; Stern E; Wolkove N; Kreisman H
Ann Emerg Med; 1999 Mar; 33(3):304-9. PubMed ID: 10036345
[TBL] [Abstract][Full Text] [Related]
27. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
Nathan RA; Nolop KB; Cuss FM; Lorber RR
Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
[TBL] [Abstract][Full Text] [Related]
28. A comparison of inhaled salbutamol with a combination of salbutamol and beclomethasone dipropionate in moderately severe asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1994; 36(3):119-24. PubMed ID: 7737699
[TBL] [Abstract][Full Text] [Related]
29. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
Weir DC; Burge PS
Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
[TBL] [Abstract][Full Text] [Related]
30. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
Ponticiello A; Vatrella A; Parrella R; Romano L; Zofra S; Berlingieri GM; Bariffi F
Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
[TBL] [Abstract][Full Text] [Related]
31. Inhaled therapy reduces morning dips in asthma.
Horn CR; Clark TJ; Cochrane GM
Lancet; 1984 May; 1(8387):1143-5. PubMed ID: 6144875
[TBL] [Abstract][Full Text] [Related]
32. [Effect of long-term treatment with an inhaled corticosteroid on bronchial hyper-responsiveness and clinical asthma in asthmatic subjects].
Ikuta N; Kondoh Y; Tangiguchi H; Gotoh K; Yanagisawa K; Suzuki R; Takagi K
Arerugi; 1996 Dec; 45(12):1231-6. PubMed ID: 9133333
[TBL] [Abstract][Full Text] [Related]
33. Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma.
van der Heide S; de Monchy JG; de Vries K; Bruggink TM; Kauffman HF
J Allergy Clin Immunol; 1994 Feb; 93(2):470-5. PubMed ID: 8120274
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
35. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
[TBL] [Abstract][Full Text] [Related]
36. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
[TBL] [Abstract][Full Text] [Related]
37. [Effect of one year of treatment with inhaled beclomethasone dipropionate on airway hyperresponsiveness in stable chronic asthma].
Ikeda A; Nishimura K; Koyama H; Tsukino M; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):505-9. PubMed ID: 7609335
[TBL] [Abstract][Full Text] [Related]
38. Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.
O'Connor BJ; Löfdahl CG; Balter M; Szczeklik A; Boulet LP; Cairns CB
Respir Med; 2007 Jun; 101(6):1088-96. PubMed ID: 17360171
[TBL] [Abstract][Full Text] [Related]
39. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
40. [Effect of low dose of inhaled corticosteroid combined with small dose of oral theophylline on treatment of bronchial asthma].
Li J; Mo H; Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):336-9. PubMed ID: 11778513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
